Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2012.09.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Triple-Negative Breast Cancer

2018English

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction With Clinical Outcome

PLoS ONE
Multidisciplinary
2014English

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity Before and After Neoadjuvant Chemotherapy

Cancers
Cancer ResearchOncology
2019English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

CD155 Contributes to the Mesenchymal Phenotype of Triple‐negative Breast Cancer

Cancer Science
Cancer ResearchMedicineOncology
2020English

MiR-34b Is Associated With Clinical Outcome in Triple-Negative Breast Cancer Patients

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2012English

A Multigene Predictor of Metastatic Outcome in Early Stage Hormone Receptor-Negative and Triple-Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy